We founded Precision Medicine Group in 2012 because we believed there was a transformational opportunity to improve the process of bringing new drugs to market. It involves utilizing technology, data, and human expertise. It is a big challenge that requires diverse talents. Our model involves both nurturing and investing organically and acquiring capabilities that we do not have but critically need. Our core executive team is anchored to this model, building life science services that address fundamental changes in healthcare that are necessary for health and outcomes improvement.
External link for Precision Medicine Group
2 Bethesda Metro Center
Suite 850
Bethesda, Maryland 20814, US
Precision Medicine Group reposted this
In this edition of our Precision Manufacturing newsletter, our biotech experts dive into essential asset strategies for driving innovation, managing risk, and fueling long-term growth. Click below to read more and subscribe today for more insights! #Biopharma #Biotech #CDMO #MakevsBuy
As 2024 wraps up, major biotech developments are setting the stage for the new year ahead. In this episode of Manufacturing Milestones, Anshul Mangal discusses recent moves that are reshaping the future of the industry. Watch now for the latest developments including: -> The BIOSECURE Act -> Novo's $16.5B acquisition of Catalent -> Eli Lilly's $3B investment in Wisconsin Facility #Biotech #Innovation #MergersAndAcquisitions #ManufacturingMilestones
Despite the BIOSECURE Act’s uncertain future, its influence on pharma supply chains remains strong. Project Farma (PF)’s Anshul Mangal shared his expert insights with Citeline’s Pink Sheet on how the act is driving long-term shifts in supplier strategies, halting U.S. expansion plans by Chinese firms, and fueling concerns around geopolitical risks. Click here to read more: https://lnkd.in/eEXUKsBh #PharmaSupplyChains #BIOSECUREAct #Biotech
Our CEO, Margaret Keegan, is featured in the December issue of Pharmaceutical Executive candidly discussing the future of clinical development, the changing commercialization sector and the manufacturing of tomorrow’s medicines. The article also highlights what is possible now with AI and how Precision is helping navigate biotechnology and pharmaceutical companies into the next era of healthcare: https://lnkd.in/eSF4Dx5C #clinical #manufacturing #research #biotechnology #pharmaceutical #drugspharmaceuticals #health #healthcare #womeninscience #science
The accelerated approval of sotorasib for KRAS-mutated lung cancer sparked critical discussions about dosing, trial design, and patient-centered care. Precision Chief Medical Officer, Harpreet Singh, MD, joins Matthew Hadfield, DO, to share lessons learned and explore how these insights are shaping the future of oncology trials. Watch the full interview to learn more: https://lnkd.in/e9CxCy7Q
Exciting news! Our 2024 Environmental, Social, and Governance (ESG) report is here. This year, we’ve made meaningful progress, embedding ESG principles into our strategies to drive impactful change, foster sustainability, and deliver long-term value for all stakeholders. We’re proud of what we’ve accomplished and even more inspired to continue shaping a brighter, more sustainable future. https://hubs.ly/Q02-Vszb0 #ESG #Sustainability #CorporateResponsibility #Healthcare #Biotech
Precision Medicine Group reposted this
In biotech, automation is critical for efficiency and compliance -- but with so many options, how do you choose the right strategy? In the latest edition of our Precision Manufacturing newsletter, our team of experts outline steps to design a flexible, scalable automation plan that aligns with your current and future needs, from process control to regulatory compliance. Click below to read our guide to a successful automation strategy and subscribe today for more insights. #Biotech #Automation #Compliance #AdvancedTherapies
In this episode of Manufacturing Milestones, Jacob Greenwood, SVP of Business Development at Project Farma (PF), breaks down recent strategic moves across the biomanufacturing industry. Unmute to hear Jake discuss: - Ascend Advanced Therapies’ acquisition of Advanced BioScience Laboratories to expand AAV vector production - Avid Bioservices’ $850M private equity buyout to scale operations - Lonza’s investment in sustainable bioconjugation manufacturing suite in Switzerland What recent developments in biomanufacturing have caught your attention? #Biomanufacturing #AdvancedTherapies #GeneTherapy #ManufacturingInnovation
Exciting news coming out of AMP 2024: Announcing a strategic partnership and presentation with Agena Bioscience to bridge critical gaps in detecting mutations not identified by next-generation sequencing (NGS) alone. https://hubs.ly/Q02-l1tq0 #AMP